GIGAMUNE, INC.
San Francisco, CA · Biotech · Private
Engineered TCR-regulatory T cell therapies targeting type 1 diabetes autoantigens
gigamune.com →- Grants
- $2.8M
- 9 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 15
- 3 granted · 12 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201820192020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Recombinant TIL Cell Therapy for Salvage Solid Tumor Patients | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Engineered TCR-T Cell Therapy Targeting Driver Mutations in NSCLC | $400,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Engineered TCR-T Cell Therapies Targeting Shared Tumor Associated Antigens | $400,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Engineered TCR-Treg Cell Therapies Targeting Type 1 Diabetes Autoantigens | $355,000 | |
| Federal grant | Department of Health and Human Services · Phase I · In vivo Gene Delivery to Regulatory T Cells to Drastically Reduce the Cost of Regulatory T Cell Therapy | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Engineered TCR-Treg Cell Therapies Targeting Type 1 Diabetes Autoantigens | $55,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Delivery of Full Length Dystrophin to Muscle Cells for DMD Gene Therapy | $295,294 | |
| Federal grant | Department of Health and Human Services · Phase I · In vivo Sickle Cell Disease Gene Therapy Using a Novel Virus Like Particle | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase II · A Novel Lentivector for Enhanced In Vivo Delivery of T Cell Receptors for Cell Therapy for Stage IV Melanoma | $400,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1407 | Bedrock Therapeutics, Inc. | — | — |
| 1408 | Integrated Protein Technologies, Inc. | — | — |
| 1409 | PHOTONIC PHARMA, LLC | — | — |
| 1410 | GIGAMUNE, INC. | — | — |
| 1411 | Complex Computation, LLC | — | — |
| 1412 | Mirai Bio | — | — |
| 1413 | Abcombi Biosciences Inc | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Engineered Enveloped Vectors And Methods Of Use Thereofapplication
- Engineered Cells Expressing Anti-Viral T Cell Receptors and Methods of Use Thereofgranted
- Engineered Enveloped Vectors And Methods Of Use Thereofgranted
- Nucleic Acid-Guided Nucleasesapplication
- Novel Nucleic Acid-guided Nucleasesapplication
- Engineered Cells Expressing Anti-viral T Cell Receptors And Methods Of Use Thereofgranted
- Engineered Cells Expressing Anti-tumor T Cell Receptors And Methods Of Use Thereofapplication
- Engineered Cells Expressing Anti-tumor T Cell Receptors And Methods Of Use Thereofapplication
- Engineered Cells Expressing Anti-viral T Cell Receptors And Methods Of Use Thereofapplication
- Engineered Enveloped Vectors And Methods Of Use Thereofapplication
- Engineered Retroviruses for Gene Delivery, Modulation of Target Cell Function, and Protein Library Screeningapplication
- Novel Nucleic Acid-guided Nucleasesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.